Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 81

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 81
---
 significant change in our financial or trading position since December 31, 2024.

<div align='center'>S-44</div>

TABLE OF CONTENTS

### LEGAL MATTERS
The validity of the notes and the guarantees and certain legal matters in connection with the notes will be passed upon for us by Allen Overy Shearman Sterling US LLP, New York, New York, for AMS Europe by Baker & McKenzie Amsterdam N.V. as to matters of Dutch law, and for the underwriters by Simpson Thacher & Bartlett LLP, New York, New York.

### EXPERTS
The consolidated financial statements of Boston Scientific Corporation appearing in Boston Scientific Corporation’s Annual Report (Form 10-K) for the year ended December 31, 2024 (including the schedule appearing therein), and the effectiveness of Boston Scientific Corporation’s internal control over financial reporting as of December 31, 2024 have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such financial statements are, and audited financial statements to be included in subsequently filed documents will be, incorporated herein in reliance upon the reports of Ernst & Young LLP pertaining to such financial statements and the effectiveness of our internal control over financial reporting as of the respective dates (to the extent covered by consents filed with the Securities and Exchange Commission) given on the authority of such firm as experts in accounting and auditing.

<div align='center'>S-45</div>

TABLE OF CONTENTS

### WHERE YOU CAN FIND MORE INFORMATION
Boston Scientific is subject to the informational requirements of the Exchange Act, and, in accordance therewith, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Boston Scientific’s SEC filings are available on the SEC’s website at http://www.sec.gov . You can also find information about us by visiting our website at www.bostonscientific.com . We have included our website address as an inactive textual reference only. Information on, or accessible through, our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus.

#### Incorporation by Reference
We are “incorporating by reference” specific documents that we file with the SEC, which means that we can disclose important information to you by referring you to those documents that are considered part of this prospectus supplement and the accompanying prospectus. Information that we file subsequently with the SEC will automatically update and supersede this information. We